Additionally, the adjusted mean high-sensitivity CRP (hs-CRP) was 3.0 mg/L (95% CI, 2.6-3.5) vs median values of 1.12 mg/L in colchicine treated patients in the COLCOT trial. “These data are ...

Colchicine again reduced cardiovascular events, this time in stable ischemic heart disease, in the LoDoCo2 trial from 2020.